Saudi Critical Care Society clinical practice guidelines on the prevention of venous thromboembolism in adults with trauma: reviewed for evidence-based integrity and …

M Amer, MS Alshahrani, YM Arabi, A Al-Jedai… - Annals of Intensive …, 2023 - Springer
Background To develop evidence-based clinical practice guidelines on venous
thromboembolism (VTE) prevention in adults with trauma in inpatient settings. Methods The …

[HTML][HTML] Infectious diseases pharmacy practice, education, and research in Saudi Arabia: A review and future perspectives by the Infectious Diseases Pharmacy …

YS Alsowaida, AK Thabit, TA Almangour… - Saudi Pharmaceutical …, 2022 - Elsevier
Background Infectious diseases (ID) pharmacy is one of the rapidly evolving clinical
pharmacy specialties in the Kingdom of Saudi Arabia (KSA). There are gaps in the literature …

Clinical characteristics and outcome of Covid-19 illness and predictors of in-hospital mortality in Saudi Arabia

MA Abolfotouh, A Musattat, M Alanazi, S Alghnam… - BMC Infectious …, 2022 - Springer
Background Patients' race and ethnicity may play a role in mortality from Covid-19. Studies
in China, the US, and Europe have been conducted on the predictors of Covid-19 mortality …

Exploration of sex and age-based associations in clinical characteristics, predictors of severity, and duration of stay among COVID-19 Patients at the University …

RA Assiri, A Bepari, W Patel, SA Hussain, SK Niazi… - Healthcare, 2023 - mdpi.com
COVID-19 infection has a spectrum of variable clinical severity between populations
because of their characteristic demographic features, co-morbidities, and immune system …

COVID-19 thromboprophylaxis. New evidence

R Ferrandis, P Sierra, A Gomez-Luque - Revista Española de …, 2023 - Elsevier
Recent publications have questioned the efficacy of using therapeutic or intermediate doses
of low molecular weight heparin in COVID-19 patients, especially in the most severe …

A comparison of three thromboprophylaxis regimens in critically ill COVID-19 patients: An analysis of real-world data

A Alrashed, P Cahusac, YA Mohzari… - Frontiers in …, 2022 - frontiersin.org
Introduction Thrombotic complications of coronavirus disease 2019 (COVID-19) have
received considerable attention. Although numerous conflicting findings have compared …

Tromboprofilaxis en COVID-19. Nuevas evidencias

R Ferrandis, P Sierra, A Gomez-Luque - Revista Española de …, 2023 - Elsevier
Recientes publicaciones han puesto en duda la eficacia de la utilización de dosis
terapéuticas o intermedias de heparina de bajo peso molecular (HBPM) en pacientes …

Evaluation of the Response Rates of Hospitals in the Prevention and Control of COVID-19 in Hamadan Province of Iran

MA Seif Rabiei, F Keramat, I Sedighi… - Health Services …, 2023 - journals.sagepub.com
The COVID-19 pandemic has challenged the capacity of health systems in various
countries. This study was designed to evaluate the response rates of hospitals in the …

[HTML][HTML] When antivirals backfire: An evaluation of favipiravir's clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study

K Al Sulaiman, O Aljuhani, GB Korayem… - Journal of Infection and …, 2023 - Elsevier
Background Favipiravir is an oral antiviral, that might treat COVID-19 by enhancing viral
eradication, particularly in patients with mild-to-moderate disease. Yet, the findings on the …

Which Thromboprophylaxis Dose Gives the Best Clinical Outcomes Among Critically Ill COVID-19 Patients? A Multicenter Cohort Study

AAH Alrashed - 2023 - search.proquest.com
Introduction: Thrombotic complications of coronavirus disease 2019 (COVID-19) have
received considerable attention. Although numerous conflicting findings have compared …